Utama › Lupus › New York › New York City
Kajian klinikal Lupus di New York City, NY
18 kajian untuk Lupus sedang mencari peserta di lokasi dalam dan sekitar New York City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Mengambil pesertaFasa 2
- Columbia University Medical Center, New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Mengambil pesertaFasa 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Mengambil pesertaFasa 3
- Sl0044 50077, New York
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Mengambil pesertaFasa 3
- Research Site, New York
HEALTH Home Urinalysis Testing
Mengambil peserta
- NYU Langone Health, New York
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
Mengambil pesertaFasa 1/2
- Research Site, New York
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Mengambil pesertaFasa 1
- Icahn School of Medicine at Mount Sinai, New York
A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
Mengambil pesertaFasa 4
- New York University School Of Medicine, New York
Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
Mengambil pesertaFasa 2
- Icahn School of Medicine at Mount Sinai, New York
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
Mengambil pesertaFasa 3
- VA NY Harbor Healthcare System, New York
- NYC Health + Hospitals/Bellevue, New York
- NYU Langone Health, New York
- dan 2 lagi
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Mengambil pesertaFasa 2
- NYU Langone Health, New York
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
Mengambil pesertaFasa 1
- Columbia University Medical Center, New York
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Mengambil pesertaFasa 1
- Montefiore Medical Center, New York
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- NYU Langone Medical Center/Hospital for Joint Diseases, New York
- Hospital for Special Surgery, New York
Alnuctamab for Refractory SLE (LATTE Study)
Mengambil pesertaFasa 1
- Icahn School of Medicine at Mount Sinai, New York
Lupus Landmark Study: A Prospective Registry and Biorepository
Mengambil pesertaKajian pemerhatian
- Columbia University Medical Center, New York
- Northwell Health, New York
Safety of the Herpes Zoster Subunit Vaccine in Lupus
Mengambil pesertaFasa 4
- NYU Langone Health, New York
Safety and Efficacy of ONT01 in Lupus
Mengambil pesertaFasa awal 1
- Hospital for Special Surgery, New York
Kajian Lupus di bandar lain
- Houston, TX13 kajian
- Durham, NC12 kajian
- Miami, FL11 kajian
- Washington, DC10 kajian
- Tampa, FL9 kajian
- Philadelphia, PA9 kajian
- Clearwater, FL8 kajian
- Santa Monica, CA8 kajian
- Oklahoma City, OK8 kajian
- Los Angeles, CA8 kajian
- Chicago, IL8 kajian
- Boston, MA8 kajian
Kajian lain di New York City
- Kanser Payudara136 kajian
- Kanser Paru-paru Bukan Sel Kecil121 kajian
- Kanser (semua jenis)109 kajian
- Kanser Prostat103 kajian
- Kanser Metastatik93 kajian
- Kanser Kolorektal78 kajian
- Kanser Ovari69 kajian
- Kanser Paru-paru60 kajian
- Mieloma Pelbagai60 kajian
- Kanser Pankreas60 kajian
- Kanser Endometrium52 kajian
- Leukemia Mieloid Akut51 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.